Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus "Treat All" Adoption in Uganda

Esther Nasuuna1, Mark W Tenforde2,3, Alex Muganzi1

  • 1Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Insights

CD4 testing rates in Uganda dropped significantly after the "Treat All" policy. Many patients still present with advanced HIV disease, indicating a critical gap in care despite policy changes.

Area of Science:

  • Public Health
  • Infectious Diseases
  • HIV/AIDS Research

Background:

  • The

Purpose of the Study:

  • To analyze trends in CD4 testing rates and the prevalence of advanced HIV disease in Uganda following the

Main Methods:

  • Retrospective analysis of CD4 testing data and patient demographics.
  • Examination of HIV disease staging at the time of diagnosis or testing.

Main Results:

  • CD4 testing rates decreased from 73% in 2013 to 21% in 2018.
  • In 2018, 24% of tested individuals had advanced HIV disease (CD4 < 200 cells/µL).
  • 83% of those with advanced disease presented with WHO stage I/II disease.

Conclusions:

  • A dramatic decline in CD4 testing occurred despite the